US stock · US markets · public data

WST

West Pharmaceutical Services Inc · Healthcare

Reference price$375.73Updated according to the public source
P/E48.29
P/B8.85
ROE19.09%
DY 12M0.23%
Net margin—
Net debt/equity—
Market capUS$ 26.4 B
Volume (shares)195,972
SectorHealthcare
Overview

About WST

Demonstrações públicas consolidadas + SEC Company Facts

West Pharmaceutical Services Inc (WST) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
03/21
06/21
03/22
06/22
03/23
06/23
03/24
06/24
03/25
06/25
09/25
03/26
Income in shown records$2.34
DY 12M0.23%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-03-31Dividendo declarado$0.22
Period ending 2025-09-30Dividendo declarado$0.22
Period ending 2025-06-30Dividendo declarado$0.21
Period ending 2025-03-31Dividendo declarado$0.21
Period ending 2024-06-30Dividendo declarado$0.20
Period ending 2024-03-31Dividendo declarado$0.20

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$2,949,800,000.00$2,893,200,000.00$3,074,100,000.00—
Gross Profit$1,129,200,000.00$998,500,000.00$1,104,000,000.00—
Operating Income$676,000,000.00$569,900,000.00$584,900,000.00—
Net Income$593,400,000.00$492,700,000.00$493,700,000.00—
EPS Diluted$7.88 / share$6.69 / share$6.79 / share—

Balance sheet

Account2023202420252026
Total Assets$3,829,500,000.00$3,643,400,000.00$4,270,000,000.00—
Total Liabilities$948,500,000.00$961,100,000.00$1,094,000,000.00—
Total Equity$2,881,000,000.00$2,682,300,000.00$3,176,000,000.00—
Long-term Debt$72,800,000.00$202,600,000.00$202,800,000.00—
Current Debt$134,000,000.00$0.00$0.00—
Shares Outstanding74,135,554 shares73,299,296 shares72,303,766 shares72,021,491 shares
Cash & Investments————

Cash flow

Account2023202420252026
Operating Cash Flow$776,500,000.00$653,400,000.00$754,800,000.00—
Capital Expenditures$362,000,000.00$377,000,000.00$285,900,000.00—
Dividends Paid$57,000,000.00$59,100,000.00$61,200,000.00—
Free Cash Flow$414,500,000.00$276,400,000.00$468,900,000.00—
FAQ

Frequently asked questions

What is the price of WST?

The reference price available for WST is $375.73.

What is the P/E of WST?

The P/E ratio of WST is 48.29. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of WST?

The P/B of WST is 8.85. This compares price with reported book value per share.

What is the ROE of WST?

The ROE (Return on Equity) of WST is 19.09%. This relates the reported net result to shareholders' equity.

What is the dividend yield of WST?

The dividend yield of WST is 0.23%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of WST?

The market capitalization of WST is US$ 26.4 B.

What sector is WST in?

WST operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.